About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: September 24, 2009
What Companies Should Do Between Now and The Part 15 Hearing on Social Media
The stunning news of the week has been that the Food and Drug Administration is finally doing what it should have done long ago and called for a Part 15 hearing on social media. A Part 15 meeting is an … Continue reading
Posted in FDA Policy, New and Social Media
2 Comments